second primary cancer
Showing 1 - 25 of >10,000
Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)
Not yet recruiting
- Recurrent Cancer
- +2 more
-
Lyon, FranceCentre Léon Bérard
May 12, 2023
AI & Radiomics for Stratification of Lung Nodules After
Recruiting
- Indeterminate Pulmonary Nodules
- +3 more
- Non-Interventional Study
-
London, United Kingdom
- +1 more
May 17, 2022
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
DNA Repair and Genetic Susceptibility to Lung Cancer
Active, not recruiting
- Lung Cancer
- +2 more
- Blood draw and Questionnaires
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 3, 2022
Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)
Not yet recruiting
- Liver Metastases
- +3 more
- PVE
- +2 more
-
Warsaw, Mazowieckie, PolandSecond Department of Clinical Radiology
Sep 17, 2023
Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational
Not yet recruiting
- Metastatic Cancers
- Fatigue
- Psychoeducational Intervention
- +2 more
-
Houston, TexasMD Anderson Cancer Centerr
Oct 10, 2023
Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)
Recruiting
- Metastatic Cancer
- +5 more
- Written Exposure Therapy
-
Boulder, ColoradoUniversity of Colorado Boulder
Sep 13, 2023
Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)
Active, not recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- IMRT
- Nivolumab
-
Atlanta, Georgia
- +3 more
Jan 10, 2023
Primary Malignant Brain Tumor Trial in China (ABM-1310)
Not yet recruiting
- Primary Malignant Brain Tumor
-
Beijing, Beijing, China
- +3 more
May 28, 2023
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New York (NY-ESO-1 OLP4, NY-ESO-1 OLP4 +
Completed
- Epithelial Ovarian Cancer
- +2 more
- NY-ESO-1 OLP4
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Cancer, Cancer, Treatment-Related, Medication Adherence Trial in Chicago (Oncotool Intervention (symptom reporting + TKI
Completed
- Cancer
- +4 more
- Oncotool Intervention (symptom reporting + TKI education)
- Oncotool Control (health information)
-
Chicago, IllinoisNorthwestern University
Jan 25, 2023
Rectal Cancer Trial (Vein ligation first, Artery ligation first)
Not yet recruiting
- Rectal Cancer
- Vein ligation first
- Artery ligation first
- (no location specified)
Mar 29, 2023
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)
Recruiting
- Ovarian Cancer
- +2 more
- Paclitaxel
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 13, 2023
Breast Cancer, Cancer, Treatment-Related, Pain Cancer Trial (I-Can-Manage-Pain after cancer (Pain Management Program))
Not yet recruiting
- Breast Cancer
- +2 more
- I-Can-Manage-Pain after cancer (Pain Management Program)
- (no location specified)
Oct 20, 2023
Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China
Recruiting
- Epithelial Ovarian Carcinoma Stage III
- +5 more
- nab-paclitaxel combined with carboplatin
-
Guangzhou, Guangdong, China
- +10 more
Feb 19, 2023
Fatigue, Cancer, Treatment-Related Trial (Redsenol-1 Plus, Placebo)
Not yet recruiting
- Fatigue
- Cancer, Treatment-Related
- Redsenol-1 Plus
- Placebo
- (no location specified)
Dec 15, 2022
NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)
Not yet recruiting
- NSCLC
- +5 more
- CJRB-101
- Pembrolizumab injection
- (no location specified)
Jun 1, 2023
Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer Trial in Amsterdam (Neoadjuvant systemic therapy (CAPOX+/-B
Recruiting
- Colorectal Cancer
- +5 more
- Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
- Repeat local treatment
-
Amsterdam, NetherlandsAmsterdam UMC
May 5, 2023
Head Neck Cancer Trial in Oslo (FDG-PET guided dose painting)
Active, not recruiting
- Head and Neck Cancer
- FDG-PET guided dose painting
-
Oslo, NorwayOslo University Hospital
Apr 29, 2022
Previously Treated Primary Immune Thrombocytopenia Trial in China (rhTPO, Eltrombopag)
Recruiting
- Previously Treated Primary Immune Thrombocytopenia
-
Guangzhou, Guangdong, China
- +15 more
Jan 24, 2023
Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)
Completed
- Cancer, Treatment-Related
- +3 more
- cryoablation
-
Roma, ItalySapienza University of Rome
Feb 13, 2023
High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)
Not yet recruiting
- High Grade Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine
- Carboplatin
- (no location specified)
Jul 11, 2022
Palliative Primary Tumor Resection in Minimally Symptomatic
Recruiting
- Colorectal Neoplasms
- +12 more
- surgery of the primary tumour
- chemotherapy
-
Moscow, Russian FederationRyzhikh National Medical Research Center of Coloproctology
Apr 2, 2022
Cancer Pain, Cancer, Distress, Emotional Trial in Seongnam-si (Mindfulness-Based Cognitive-behavioral Therapy for Distress)
Not yet recruiting
- Cancer Pain
- +5 more
- Mindfulness-Based Cognitive-behavioral Therapy for Distress
-
Seongnam-si, Kyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Mar 2, 2023
Lung Cancer Trial in United States (cytology specimen collection procedure, immunoenzyme technique, study of high risk factors)
Completed
- Lung Cancer
- cytology specimen collection procedure
- +2 more
-
Tampa, Florida
- +4 more
Jun 8, 2022